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Abstract
Background: Integration of methadone maintenance therapy (MMT) and HIV services is an evidence-based
intervention (EBI) that benefits HIV care and reduces costs. While MMT/HIV integration is recommended by the
World Health Organization and the Centers for Disease Control and Prevention, it is not widely implemented, due
to organizational and operational barriers. Our study applied an innovative process to identify implementation
strategies to address these barriers.
Methods: Our process was adapted from the Expert Recommendations for Implementing Change (ERIC) protocol
and consisted of two main phases. In Phase 1, we conducted 16 in-depth interviews with stakeholders and
developed matrices to display barriers to integration. In Phase 2, we selected implementation strategies that
addressed the barriers identified in Phase 1 and conducted a poll to vote on the most important and feasible
strategies among a panel with expertise in cultural context and implementation science.
Results: Barriers fell into two broad categories: policy and programmatic. At the policy level, barriers included lack
of a national mandate, different structures (MMT vs. HIV clinic) for cost reimbursement and staff salaries, and
resistance on the part of staff to take on additional tasks without compensation. Programmatic barriers included the
need for cross-training in MMT and HIV tasks, staff accountability, and commitment from local leaders. In Phase 2,
we focused on programmatic challenges. Based on voting results and iterative dialogue with our expert panel, we
selected several implementation strategies in the domains of technical assistance, staff accountability, and local
commitment that targeted these barriers.
Conclusions: Key programmatic barriers to MMT/HIV integration in Vietnam may be addressed through
implementation strategies that focus on technical assistance, staff accountability, and local commitment. Our
process of identifying implementation strategies was simple, low cost, and potentially replicable to other settings.
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research, Implementation science
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Background
The process of translating evidence-based interventions
(EBIs) to real-world settings is a critical step in the re-
search to practice continuum. But this step is frequently
neglected in the public health sector [1–4]. The field of
implementation science has rapidly expanded to address
this gap within public health [5] and, more specifically,
within HIV research [6–8]. While the effectiveness of EBIs
can be achieved in a real-world HIV context [9–11], how
EBIs are implemented clearly affects their effectiveness
and sustainability [12]. In other words, implementation
outcomes, such as feasibility and acceptability, are directly
linked to HIV effectiveness outcomes in the real world [5].
Several evidence-based implementation strategies are
being used to facilitate the complex process of moving
EBIs into real-world settings [2, 4, 13, 14]. Although
many implementation strategies [15, 16] and taxonomies
[16–18] have been developed, the potential effectiveness
of these implementation strategies in specific settings is
uncertain [4, 14]. Service settings vary substantially with
regard to contextual factors such as patient characteristics
[19, 20], provider attitudes toward an EBI [21],
organizational readiness [22], leadership [23], and policies
[24]. These contextual factors can, in turn, influence the
success of implementation strategies [4, 14]. While strat-
egies designed to address context-specific barriers and fa-
cilitators are more likely to succeed [4, 14], the process of
selecting the most effective strategy for an EBI in a given
context can be overwhelming. Recently, guidelines to fa-
cilitate this process of selecting implementation strategies
for specific contexts have been developed [14]. For ex-
ample, the Expert Recommendations for Implementing
Change (ERIC) protocol is a four-stage, mixed-methods
process to develop expert recommendations regarding im-
plementation strategies for a given context [14].
Integration of opioid substitution therapy, such as metha-
done maintenance therapy (MMT), and HIV related ser-
vices is an EBI that leads to increased engagement of
people who inject drugs (PWID) in HIV prevention and
treatment [25–33]. HIV-infected PWID who participate in
integrated drug treatment and HIV services experience sev-
eral benefits [34]. They experience less bureaucracy acces-
sing and engaging in services; increased monitoring of drug
interactions and side effects from MMT and the provision
of antiretroviral treatment (ART) for HIV [35–45]; reduced
HIV stigma from providers; consolidated drug use and HIV
counseling; and health care delivery systems that are tar-
geted and user-friendly [46–48]. In addition, integration of
drug treatment and HIV care services reduces costs [49, 50]
and is cost-effective [51, 52], which is critically important in
low- and middle-income countries. Combining services
increases efficiency and lowers costs by reducing space
requirements and building a cadre of providers with
multiple skillsets.
Opioid substitution/HIV care integration is endorsed
by international agencies [53, 54] to address dispropor-
tionately low access to ART among HIV-infected PWID
[55]. Only one in ten PWID living with HIV receives
ART [56]. Those who have accessed ART have generally
low adherence and poor HIV disease-related outcomes
[57–59]. When PWID living with HIV have access to
MMT, they increase ART uptake [60–62] and ART adher-
ence [58, 60, 63–69], have improved HIV viral suppression
[68–70], and live longer [71]. Additionally, integrating
MMT and HIV services optimizes these effects by increas-
ing ART initiation and adherence [25–27] and improving
viral suppression [26, 27].
Despite improved outcomes for PWID with MMT/
HIV service integration, the most effective approaches to
the implementation of MMT/HIV integration have not
been identified [72], and integrated services have not been
implemented widely [73, 74]. Past integration efforts have
faced multiple barriers including organizational and polit-
ical constraints, overburdened clinicians struggling to take
on new responsibilities, and a lack of leadership invest-
ment at all levels [50, 75–77]. In Vietnam, integrated
MMT/HIV clinics, piloted by the Vietnam Administration
for HIV/AIDS Control (VAAC), the division of the Minis-
try of Health responsible for HIV services, have had varied
success [78, 79], underscoring the need for implementa-
tion strategies to ensure effective implementation across
integrated clinics. In this study, we sought to understand
common barriers and subsequently select implementation
strategies that could effectively address core challenges for
integrated MMT/HIV clinics in Vietnam. We applied an
innovative implementation science approach based on the
ERIC protocol, to assess barriers and facilitators to MMT/
HIV integration and used this assessment as a foundation
for identifying appropriate implementation strategies
within the Vietnam context.
Methods
To identify implementation strategies, we used a stream-
lined process adapted from the ERIC protocol by Waltz et
al. although we omitted the Delphi process and concept
mapping given limited resources and time [14]. We used
the ERIC methodological template to advance our two
core aims: (1) understanding barriers and facilitators to
MMT/HIV integration using qualitative interviews and a
process of prioritization with multiple stakeholders and (2)
identifying the most important and feasible implementa-
tion strategies for effective MMT/HIV integration through
voting and an iterative dialogue with our expert panel.
Phase 1
We conducted semi-structured in-depth interviews
(IDIs) with key stakeholders in Vietnam between
December 2014 and February 2015 to explore the range
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of definitions and attitudes regarding MMT/HIV inte-
gration as well as barriers and facilitators to the process.
The study was reviewed and approved by the University
of North Carolina at Chapel Hill (UNC) Institutional
Review Board and the Hanoi School of Public Health
Institutional Review Board.
Participants (n = 16) were purposively selected based
on their role in the Vietnam health system and their ex-
perience with integrated MMT/HIV clinics. They repre-
sented three categories: (1) central-level stakeholders:
VAAC staff (n = 3) and a staff member from a non-
governmental organization (NGO) that provides tech-
nical assistance to MMT/HIV pilot integration clinics
throughout Vietnam (n = 1); (2) Department of Health
and clinic directors (n = 5): and (3) clinic staff: care pro-
viders (n = 7) from stand-alone clinics in one province
and pilot integration clinics in two provinces. Interview
guide content was based on our literature review of
MMT/HIV integration and informal meetings with
NGO staff members with experience in integration in
Vietnam. Separate guides were developed for each par-
ticipant category (Additional files 1, 2, 3, 4, 5). Content
was similar across guides but tailored to probe on spe-
cific experiences and glean insights from each partici-
pant category. For example, central-level stakeholders
were asked, “Let’s say that you wanted to initiate a national
goal to integrate HIV and MMT services in Vietnam for
the VAAC. Walk me through what exactly would need to
be done in order to integrate services from the national
level, down to the clinic level” whereas clinic staff level
were asked, “Can you tell me how (you think) integration
of services [would] affect you and your role?”
IDIs were conducted by experienced ethnographers
who participated in an intensive 1-week training on the
objectives of the study and the interview guides. The in-
terviews were conducted privately in participants’ offices
or at the clinics for about 1 hour. Interviews were audio-
taped, transcribed, and translated from Vietnamese to
English. Permanent UNC Vietnamese staff, who are flu-
ent in English and who have more than 5 years of ex-
perience in technical translations for our research team,
conducted the translations. The codebook was devel-
oped based on the interview guides and an initial review
of the translated interviews. Codes included definitions,
attitudes, barriers, facilitators, and outcomes of MMT/
HIV integration. Translated interviews were coded and
reports were generated for analysis using Atlas.ti v.7 data
analysis software. Ten percent of transcripts were
double-coded by two coders to ensure coding reliability.
Any inconsistencies were discussed and resolved. The
analysis consisted of a search for themes, trends, and
emerging patterns among the three stakeholder categor-
ies: (1) central-level stakeholders, (2) Department of
Health and clinic directors, and (3) clinic staff. Based on
coded and categorized data, we created a comprehensive
matrix to identify common threads and contrasts across
and within stakeholder levels. For example, stakeholders
at all levels identified ongoing technical assistance as an
important facilitator while only clinic directors and staff
voiced concerns about low staff morale due to the
addition of new tasks to existing duties.
We reviewed the matrix and divided barriers and facil-
itators into two categories: policy and programmatic.
We confirmed findings at this stage through a separate
face-to-face meeting with each of the central-level stake-
holders in Vietnam, with bi-directional translation pro-
vided by a Vietnamese member of our UNC research
team as needed. Policy barriers comprised inconsisten-
cies in service structures and staffing in MMT and HIV
clinics. Programmatic challenges comprised technical as-
sistance for clinic staff, staff accountability, and local
commitment. In Phase 2, we focused on implementation
strategies to address programmatic challenges since they
were potentially modifiable through external intervention.
Phase 2
Using a compilation of 73 implementation strategies
[16], we identified 20 specific implementation strategies
that aligned with the three domains of programmatic
barriers and facilitators identified in Phase 1. For ex-
ample, under “Training,” we listed Distribute Educa-
tional Materials; Use Train-the Trainer Strategies;
Conduct Educational Outreach Visits; Conduct Ongoing
Training; Develop Educational Materials; Make Training
Dynamic; Provide Local Technical Assistance; and Pro-
vide Ongoing Consultation. A challenge was to create a
list that was comprehensive, concise, and where strat-
egies were discrete. Working with two experts from the
Implementation Research Institute in Washington Uni-
versity in St. Louis [80] and the Gillings School of Global
Public Health at UNC, we circulated our preliminary list,
identified overlapping strategies, and, where appropriate,
combined complementary strategies. For example, we
determined that the strategy, “Provide Ongoing Consult-
ation” overlapped with the strategy “Provide Local Tech-
nical Assistance” and so created a combined strategy:
“External Technical Assistance and Ongoing Consult-
ation.” By combining strategies where appropriate, we
were able to reduce the total number of potential imple-
mentation strategies to 16 within the three program-
matic domains.
To select the most appropriate implementation strat-
egies from the 16, we asked our panel to vote using a
web-based, self-administered survey. The panel com-
prised four Vietnamese stakeholders who were familiar
with the Vietnamese context of MMT/HIV integration
and five implementation science experts who were famil-
iar with the application of implementation strategies in a
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range of settings. Implementation science experts were
selected on the basis of their implementation science-re-
lated publications, mentorship, and grant records (i.e.,
participation in at least one of each). The size of our
expert panel (n = 9) was determined by balancing con-
siderations of practicality with the ability to capture a
range of perspectives. The survey briefly introduced
MMT/HIV integration, the EBI, and the Vietnam con-
text. Our expert panel scored each potential strategy
from 1 to 10 in terms of feasibility and importance, 1
being the least feasible and important and 10 being the
most feasible and important. We asked members to
consider feasibility and importance jointly in their
score. Members were able to weigh the relative signifi-
cance of feasibility and importance into their overall
recommendation score, as they felt appropriate. The
survey also included space to comment on scoring of
the technical assistance, staff accountability and local
commitment sections. These qualitative data allowed
us to characterize variability around the recommenda-
tions and recognize the importance of cultural specifi-
city of implementation strategies. The median, mean,
and range of scores of each strategy, in combination
with the open-ended comments, determined the final
selection of implementation strategies.
Results
First, we present Phase 1 findings that include defini-
tions of integration, attitudes toward integration, and
barriers and facilitators to integration. We then present
Phase 2 findings, which describe the identification of im-
plementation strategies.
Phase 1
Definitions of integration
Not all stakeholders had direct experience with MMT/
HIV integration, yet all knew about integration and
identified co-location of services, shared clinic staff, and
joint management as essential components of integra-
tion. Clinic providers from a pilot integration clinic em-
phasized the need for all three components, noting that
their clinic has co-located MMT and HIV departments
but is not fully integrated since the departments do
not share a management board or staff. In addition to
these three components, central-level stakeholders
suggested integrated records as an important dimen-
sion of integration.
Three approaches to the integration of clinics were
identified, (1) building an MMT/HIV clinic from the
start if neither MMT nor HIV clinic already exists, (2)
adding MMT services to an existing HIV clinic using
existing facilities and staff, and (3) combining two or
more existing MMT and HIV clinics by reducing facilities
and staffing structures. The third model was considered
the most challenging model to implement by central-level
stakeholders.
Attitudes toward integration
Overall, participants were receptive to service integra-
tion, noting the benefits to both patients and the health
system. The most important benefit was identified as
better access to services and care for MMT and HIV pa-
tients. Specifically, integration was seen as reducing
transportation, financial, and logistical barriers to acces-
sing and engaging in MMT/HIV services. At the clinic
level, integration was viewed as enabling staff to provide
better care and treatment for patients. In integrated
clinics, staff can monitor treatment progress and ensure
patients receive appropriate counseling and dosages.
One clinic director’s experience illustrates the value of
integration from the perspective of a stand-alone clinic:
When we implement, there are many advantages, the
biggest advantage is for the patients…they do not have
to go anywhere, the methadone treatment doctors are
also the ones who treat HIV, they understand both
methadone, ARV [antiretroviral] for appropriate
treatment for patients. They monitor their patients
daily, then they can extract early and timely all the
side effects as well as the challenges, obstacles to the
patients… I think that whatever is beneficiary for the
community, useful for the patients, we should do.
(Clinic Director, Stand-alone Clinic)
Central-level stakeholders and some clinic directors and
providers also noted that integration could save resources
by combining or reducing staff and space. The cost-
effectiveness of integration is particularly important for
MMT and HIV programs, which have been supported al-
most exclusively by external funders, and which are now
facing imminent withdrawal of external funding. Stake-
holders at the central and clinic director levels identified
the need to transfer program support to the VAAC. Clinic
directors in particular explained that government funds
would need to replace external funds to ensure the suc-
cessful implementation and sustainability of MMT and/or
HIV services. Central-level stakeholders reiterated this
point: “Integration is the solution [to international with-
drawal of funds]. Integration is a form of personnel and
cost saving for both government and patients.” (VAAC)
Barriers and facilitators to integration
Although a range of barriers and facilitators to integration
were described during the interviews, most stakeholders
referenced five main domains. Two of these are modifiable
at the policy level (service and staffing structures) and
three are modifiable at the programmatic level (technical
assistance for clinic staff, staff accountability, and local
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commitment). Domains that were mentioned by the sim-
ple majority of participants are included in Tables 1 and 2.
Modifiable at the policy level
Service structures
All clinic directors cited the need for a central-level decree
or legal framework to successfully implement integration.
They noted that official guidance would be helpful for inte-
grated MMT/HIV services due to the inconsistent require-
ments and procedures between the two services and the
sensitive nature of substance abuse and HIV treatment.
While current systems for medical records, administra-
tive procedures, forms, and bookkeeping in MMT and HIV
clinics have been established separately, many expressed
the belief that one integrated system would be more effect-
ive. Clinic providers noted that an integrated record system
would provide complete patient records and would enable
them to monitor drug interactions and provide appropriate
care and treatment. In addition, staffing and medical dis-
pensing guidelines between MMT and HIV services are
currently inconsistent. For example, methadone doses are
dispensed daily while ARV doses are dispensed monthly. In
MMT clinics, staff are often required to work on weekends
and holidays. A few stakeholders provided suggestions to
overcome these barriers, such as permitting clinic staff to
administer methadone doses for weekends and holidays in
advance.
In addition to intra-service operational inconsistencies,
differences in client fees and provider salaries are chal-
lenges to integration. Specifically, HIV services currently
are covered by health insurance but MMT services are
not. Furthermore, MMT providers receive a “hardship”
allowance that HIV providers do not receive. Central-
level stakeholders recognized these differences and the
need to align fee and salary differences between services.
Staffing
Clinic directors and providers frequently cited heavy
workloads and staff shortages as challenges to integration.
While the need to invest in additional staff was widely rec-
ognized at the clinic level, the lack of permanent positions,
low salaries, high-risk working environments, and stigma
against PWID and HIV patients were barriers to recruit-
ing additional staff.
Clinic directors in integration pilot clinics viewed training
providers on new tasks as an alternative to recruiting add-
itional staff. However, most clinic providers in the inte-
grated clinics reported feeling tired and overwhelmed at the
prospect of additional tasks being added to their existing re-
sponsibilities. In several cases, clinic providers expressed
dissatisfaction with the idea of taking on additional
Table 1 Barriers and facilitators that are modifiable at the policy level
Level Domain Barriers Facilitators
Central Service structures • Inconsistent requirements and procedures
between MMT and HIV services (staffing,
renumeration, medical dispensing, health insurance)
• Multiple management units (district vs. province)
• Separate patient record systems
• Step-by-step instructions for implementation
at the district and province levels
• Revised medical dispensing schedule
• Unified patient record system
Staffing structures • None • Transition of staff from program status to
government employee status
DOH and clinic directors Service structures • Lack of legal framework for integration
• Inconsistent requirements and procedures
between MMT and HIV services (common
prices, health insurance, certification)
• Multiple management units
• Legal framework and regulations for
providing integrated
MMT and HIV services
• Provision of health insurance for both MMT
and HIV services
Staffing structures • Lack of full-time, permanent staff and
inability to attract external human resources
• Lack of renumeration that is commensurate
to increased responsibilities
• High-risk working environment
• None
Clinic providers Service structures • Inconsistent requirements and procedures
between MMT and HIV services (staffing,
renumeration, medical dispensing, health
insurance)
• Lack of unified reporting system
• None
Staffing structures • Lack of renumeration that is commensurate
to increased responsibilities (high workload)
• Lack of staff and inability to attract
external human resources
• Lack of government staff positions and program staff
treated differently
• High-risk working environment
• None
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responsibilities with no additional salary, noting that their
salary should be commensurate with their responsibilities.
This disparity between increased responsibilities and static
salary has decreased staff morale in both successful and un-
successful integration pilot clinics.
Clinic directors recognized the potential (or reality) of
decreased staff morale and discussed strategies that have
successfully facilitated a collaborative, supportive envir-
onment to increase staff motivation. These strategies are
discussed in further detail below under “staff account-
ability.” At the policy level, central-level stakeholders are
working on addressing issues such as task shifting and
staffing reduction.
Modifiable at the programmatic level
Technical assistance for clinic staff
Inadequate staff training was the most commonly per-
ceived barrier to integration at the programmatic level.
Both clinic directors and providers reported lack of skills
for the provision of integrated services as a challenge. At
all levels, staff training and certification were seen as sim-
ple but important facilitators to successful integration.
Clinic providers in stand-alone clinics perceived that
learning how to provide integrated services would not
be difficult. Additionally, clinic providers in both inte-
gration pilot clinics and stand-alone clinics suggested
practice-based learning as an effective teaching ap-
proach. A clinic provider recommended decreasing the
lag time between training and integration uptake to
ensure that clinic staff are able to apply their training
immediately.
Outside of staff training, clinic providers also highlighted
technical assistance activities, such as receiving educational
materials and coaching assistance as needed, to facilitate
the integration process.
Staff accountability
At the clinic level, clinic directors and providers from inte-
gration pilot clinics explained that increasing staff account-
ability would also facilitate integration implementation.
Staff accountability can be increased through knowledge
and information sharing as well as collaboration and social
support among clinic staff.
For knowledge and information sharing in an integrated
clinic, clinic-level stakeholders highlighted the importance
of clarifying staff responsibilities ranging from bookkeep-
ing and counseling to testing and reporting. One clinic
provider also mentioned that although information is
shared during meetings, information sharing and internal
communications should also be proactive and in real time.
Additionally, a clinic director suggested implementing
reporting criteria, noting that it is essential to monitor and
evaluate integrated services at the clinic level:
…from [the] beginning, we haven’t got description on
this model in our hospital as well as reporting criteria,
thus we don’t know where and how to report MMT
results. Our efforts cannot not be measured and
evaluated. (Clinic Director, Integration Pilot Clinic 1)
For collaboration and social support, clinic directors
and providers observed that heavy workloads had a det-
rimental effect on clinic staff morale. To motivate clinic
staff, a clinic director successfully created a social group
for clinic staff, where staff provided support and encour-
agement for each other. Similarly, clinic providers from
Table 2 Barriers and facilitators that are modifiable at the programmatic level
Level Domain Barriers Facilitators
Central Technical assistance • None reported • Human resource training and certification
• Technical assistance to facilitate process
Accountability • None reported • Renumeration for monitoring and evaluation
Local commitment • None reported • Local leadership buy-in informed by project evidence
DOH and clinic
Directors
Technical assistance • Lack of human resource training
• Lack of integration model description
• Patient discomfort sharing facilities with IDUs
• Human resource training and certification
Accountability • Lack of monitoring and evaluation reporting criteria • Support from medical director and other medical
departments
• Social support network for clinic staff
Local commitment • Lack of province-to-province learning opportunities • None reported
Clinic providers Technical assistance • Limited knowledge of integrated services
• Lengthy time lapse between training and clinic start-up
• Disruptive IDU patient or drug seller behavior
• Human resource training and practice
• Educational materials
• Coaching support
• Proactive information sharing between departments
Accountability • None reported • Knowledge of clinic staff responsibilities
• Proactive information sharing between departments
• Collaborative work environment
Local commitment • Lack of clinic staff buy-in • Clinic engagement with community
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a different clinic explained the importance of collabor-
ation between staff in the MMT and HIV sections:
When the MMT section is too crowded, [the HIV
provider] will help and vice versa when the HIV
section needs assistance, [the MMT provider] will
help… People keep working and assisting each other.
When it’s too crowded, we all help each other and
then get back to normal work. (Clinic Provider, Pilot
Clinic 1)
Intra-clinic collaboration increased support and com-
munication among staff and, at the same time, increased
knowledge of respective MMT and HIV responsibilities.
Local commitment
Clinic directors from both integration pilot clinics
expressed the need for strong and unified support from
health and social service authorities, hospital directors,
and hospital departments.
To create local champions for integration, a stake-
holder at the central level recommended providing local
leaders, such as clinic directors, with pilot evidence to
generate buy-in. Once buy-in is established, leaders
should be provided with technical assistance to facilitate
the integration process.
I think that the key driver for success is the local
leadership. If neither PAC [Provincial AIDS Center]
nor the leaders recognize that important role, it is
impossible to work out. The very first thing we did
was to convince the leaders, to provide them with
project evidence…Once they realize it, they lead, we
just provide them technical support, advice on steps.
If a challenge occurred, we further advise. We have
the developed plan available to facilitate the process,
to monitor it and we transfer the technology to them.
(NGO)
Some stakeholders also mentioned local leadership
commitment as a mechanism for obtaining investments
for infrastructure, equipment, human resources, and
policies to facilitate integration.
Phase 2
Implementation strategies
Vietnamese stakeholders (n = 4) and implementation sci-
ence experts (n = 5) scored each potential implementation
strategy from 1 to 10 based on feasibility and importance,
noting the rationale for their scores (Table 3).
We provided a short description of the Vietnamese
context and of each implementation strategy on the sur-
vey. In general and as anticipated, the Vietnamese stake-
holders were not as familiar with specific implementation
strategies whereas the implementation science experts
were not as familiar with the Vietnamese context. This dif-
ference in familiarity affected scores on clinic-level strat-
egies such as clinic reminders and relay of clinical data.
Several of the strategies had a narrow range of scores, sug-
gesting convergence of opinions across members of the
expert panel.
Technical assistance for clinic staff
All potential strategies within this domain were scored
highly. The lowest median score was 6.5 (educational ma-
terials), the highest median score was 9 (external technical
assistance and ongoing consultation), and scores ranged
in total between 4 and 10.
Vietnamese stakeholders and implementation science
experts provided similar responses with regard to imple-
mentation strategies in the area of technical assistance
with the exception of educational materials and ongoing
and dynamic training. For educational materials, the
Vietnamese stakeholders had a median score of 9.5 and
a range of between 7 and 10 while the implementation
science experts had a median score of 6 and a range of
between 4 and 7. One implementation science expert
provided a score of 6, noting that educational materials
are necessary but not effective for behavior change. This
comment offers one explanation for why this strategy
had a lower range among the implementation experts.
For ongoing and dynamic training, both Vietnamese
stakeholders and implementation science experts had a
Table 3 Summary of potential implementation strategies,
median scores, and score ranges
Domain Strategy Median Range
Technical assistance External technical assistance
and ongoing consultation
9 7–10
Technical assistance within
the clinic
8 7–10
Educational outreach visit 7 5–9
Ongoing and dynamic training 7.5 4–10
Educational materials 6.5 4–10
Accountability Audit and provide feedback 8 7–10
Real-time relay of clinical data 8 7–10
Quality monitoring tools 7.5 5–9
Clinical implementation team
meetings
7.5 5–9
Clinical supervision 6.5 4–10
Reminders to clinicians 6 5–10
Local commitment Identify champions 9 5–9
Capture local knowledge 8.5 7–10
Build coalition 7.5 7–10
Advisory boards/workgroups 6 4–10
Executive boards 6 4–10
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median score of 8. However, Vietnamese stakeholders
had a narrower range (6–9) compared to implementa-
tion science experts (4–10).
Overall, implementation experts commented that they
had a difficult time scoring the strategies within this do-
main because they felt that the most promising strat-
egies had been identified and that all of these strategies
were important and feasible. Vietnamese stakeholders
also commented that the strategies within this domain
were inherently interconnected.
Staff accountability
The median scores within this domain were slightly lower
than scores in the areas of technical assistance and local
commitment. The lowest median score for a strategy was 6
(reminders to clinicians) while the highest median score for
a strategy was 8 (audit and provide feedback, real-time relay
of clinical data). Scores ranged between 4 and 10. The me-
dian scores of Vietnamese stakeholders and implementa-
tion science experts were similar. However, Vietnamese
stakeholders had wide ranges (3–10) in their scoring of two
strategies (audit and provide feedback, real-time relay of
clinical data). These wide ranges were largely attributable to
one stakeholder who commented that these proposed strat-
egies were less feasible than others. Vietnamese stake-
holders also had a narrow range (7–9) of scores for the
strategy of clinical implementation team meetings, suggest-
ing a high level of agreement on the importance and feasi-
bility of this implementation strategy.
Implementation science experts had a wide range of
scores (4–10) for the strategy of clinical supervision.
However, no additional commentary was provided that
would allow us to determine possible reasons for this
range. Two implementation science experts did note
that lack of context-specific knowledge hampered their
ability to evaluate whether clinical reminders would be
helpful because in the USA, providers often ignore re-
minders. This may explain this strategy’s median score
of 6, the lowest within this domain.
Local commitment
Similar to technical assistance, all potential strategies within
this domain were scored highly with a lowest median score
of 6 (executive boards), a highest median score of 9 (identify
champions), and a total range of scores between 4 and 10.
Vietnamese stakeholders and implementation science
experts scored most of the strategies within this domain
similarly. However, there were differences in median
scores for two of the strategies (build coalition, identify
champions). Vietnamese stakeholders scored “build a co-
alition” higher (9.5) than the implementation science ex-
perts (7). On the other hand, implementation science
experts scored “identify champions” higher (10) than the
Vietnamese stakeholders (7.5), noting that local cham-
pions or opinion leaders are crucial to implementation.
The scores for the strategies within this domain varied
widely (range of 4–9 or 4–10) among Vietnamese stake-
holders. Some of this disparity is attributable to stake-
holders who believed that strategies within this domain
are less feasible than those from other domains.
Recommended implementation strategies
Based on the results of this questionnaire and further dis-
cussions with our expert panel, we identified the following
domains and strategies to be of primary importance for fa-
cilitating MMT and HIV service integration: (1) technical
assistance including the strategies: centralize ongoing in-
ternal or external technical assistance; periodic educational
outreach; and development of educational materials; (2)
staff accountability including the strategies: create audit
and feedback loops; provide clinical supervision; and clin-
ical implementation team meetings;( 3) local commitment
including the strategies: identify and prepare champion in-
dividual; build inter-clinic coalition where knowledge is
shared; and involve an executive board.
Discussion
Integration of MMT/HIV services is recognized as an EBI
and is recommended by the US Centers for Disease Con-
trol and Prevention, the US Department of Health and Hu-
man Services, and the World Health Organization [53, 54].
Overall, integration benefits PWID through reduced bur-
eaucratic and logistical barriers, increased monitoring of
drug interactions, increased attention to stigma among pro-
viders, consolidated HIV risk and drug counseling, and tar-
geted, user-friendly service delivery [46–48, 51]. In addition
to patient benefits, integration also benefits healthcare sys-
tems by reducing costs and improving efficiencies in care
[26, 49, 50], with economic models in Ukraine and Vietnam
demonstrating that MMT/HIV integration is a more cost-
effective intervention than ARTalone [51, 52].
Co-locating staff is typically insufficient for ensuring
collaboration or continuity of care [49]. Indeed, imple-
mentation strategies are needed to address barriers and
build on facilitators to guarantee effective integration of
MMT and HIV services. Given the strong evidence for
integration and the lack of clarity on best practices for
implementation in specific settings [4, 14], we identified
potential implementation strategies for the Vietnamese
context that align with the domains of technical assist-
ance, staff accountability, and local commitment.
In Phase 1 of our study, participants agreed that inte-
gration has multiple benefits to both patients and the
health care system and were generally open to MMT/
HIV integration. However, barriers at multiple levels
were noted. Barriers and facilitators to integration fell
into two domains modifiable at the policy level, service
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and staffing structures, and three domains modifiable at the
programmatic level, technical assistance for clinic staff, staff
accountability, and local commitment. At the policy level,
the need for a central-level decree was widely acknowl-
edged and considered essential before clinics could begin
the process of integration. In addition, differences in insur-
ance reimbursements and staff salaries for MMT services
as compared to HIV services need to be harmonized before
these two service structures can integrate. Concerns about
staffing reductions and resistance to taking on additional
tasks without compensation were voiced by clinic-level staff
and recognized by leadership, highlighting the need to de-
velop clear policies for shifting staff and for providing mon-
etary and non-monetary rewards for additional tasks. The
VAAC is actively working on these two policy barriers.
At the programmatic level, clinic staff provided detailed
feedback on what would be needed to operationalize clinic
integration. Main challenges within clinics were lack of
cross-training in HIV and MMT related tasks among clinic
staff, lack of communication between MMT and HIV ser-
vice providers, and lack of motivation to integrate effect-
ively. Clinic stakeholders from pilot integration clinics
reported that they were able to integrate MMT and HIV
services effectively, illustrating that policy or programmatic
barriers to integration are not insurmountable and that im-
plementation strategies can address challenges to service
integration. They observed that programmatic level facilita-
tors, such as staff training, cross-clinic collaboration, real-
time information sharing, and local leadership commit-
ment, played a large role in their success.
The key implementation barriers identified in this study,
including reluctance to add tasks to provider workloads,
lack of staff training, and lack of commitment from local
leaders, have been observed in other settings [50, 75–77],
although specific combinations of barriers and solutions
vary across country contexts. For example, in Ukraine,
regulatory bodies at the central level did not permit nurses
to simultaneously dispense TB and ART [75]. In contrast,
in Tanzania, co-dispensing is easily accomplished without
regulatory hurdles while the integration of MMT and HIV
services is impeded by a shortage of trained providers
[76]. Similar to Vietnam, China has faced inefficient co-
ordination between MMT and HIV clinics driven by bar-
riers including insufficient training and ongoing guidance,
resistance to added workload, and PWID-related stigma
among HIV providers [77]. Given these varied contexts
and the challenges faced, a process for quickly determin-
ing barriers and tailored solutions is essential.
Based on the demonstrated need for technical assistance,
staff accountability, and local commitment identified in
Phase 1, we explored, in Phase 2, potential implementation
strategies aligned with these domains and, through a voting
process, selected the most promising implementation strat-
egies. Specifically, we used a compilation of strategies [16]
and consulted with implementation experts to select a
total of 16 potential strategies for an importance and
feasibility poll.
Inclusion of both Vietnamese stakeholders and imple-
mentation science experts in the voting panel ensured ex-
pertise in both the organizational and cultural context of
Vietnam as well as the effectiveness of strategies for imple-
menting a range of EBIs. The number of members in the
panel (n = 9) allowed for both a range of perspectives as
well as a process that was not overly burdensome in terms
of following up with members and managing qualitative
responses.
As expected, scoring by Vietnamese stakeholders and
implementation scientists tended to cluster, especially in
certain domains. For example, Vietnamese stakeholders
had a median score of 9 for educational materials under
technical assistance, while implementation science ex-
perts had a median score of 6. The higher score awarded
by the Vietnamese experts reflects the familiarity, feasi-
bility, and acceptability of educational materials in the
Vietnamese setting, while the lower score, given by im-
plementation experts, stemmed from experience in the
USA where educational materials are not independently
effective in changing behaviors.
Combining quantitative and qualitative findings to in-
form our strategy selection process was particularly
helpful given the small size of our voting expert panel.
Specifically, rather than simply selecting 3–4 strategies
with the highest ranking scores, we also considered the
qualitative factors that influenced scores (elicited from
both the written comments, and sometimes, verbal or
email follow-up for further clarification as needed) as
part of our decision-making process. As a result, al-
though educational materials only had a median of 6.5,
we included it in the technical assistance package since
Vietnamese stakeholders felt it was highly acceptable
and feasible and the implementation science experts be-
lieved it was a necessary strategy within the technical as-
sistance domain.
Conclusions
Our study applied an adapted ERIC protocol [14] over a
3-month period to support a streamlined process for
identifying culturally salient and context-appropriate
EBI implementation strategies. Our process consisted of
four steps within two main phases. In Phase 1, we con-
ducted 16 in-depth interviews with particular insight
into integration in Vietnam and developed matrices to
display barriers and facilitators. In Phase 2, we selected
implementation strategies that addressed the barriers
identified in Phase 1 and conducted a poll to vote on
the most important and feasible strategies with an ex-
pert panel that incorporated expertise in cultural con-
text and implementation science. This process was
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relatively simple, low cost, and potentially replicable in
other settings.
Our stakeholders represented three levels of the
Vietnamese health system (central-level policy makers,
Department of Health and clinic directors, and clinic
staff ), three provinces, and both stand-alone and inte-
grated clinics. While our sample sizes were relatively
small, they provided us with the necessary breadth and
depth to address MMT/HIV integration in Vietnam.
Qualitative data enhanced the utility of our importance
and feasibility poll by providing rich insight into di-
mensions of each implementation strategy that may
have influenced the selection of certain scores. The
process of selecting our final strategies relied on a com-
bination of poll results and qualitative dialogue. Our
study sheds light on barriers and facilitators to MMT/
HIV integration, which may be generalizable to other
low-income settings. Furthermore, our process pro-
duced promising implementation strategies to facilitate
MMT/HIV service integration, addressing gaps in both
the substance use and implementation science litera-
ture. These implementation strategies must be further
evaluated in a field trial, using both effectiveness and
implementation outcomes. If these implementation
strategies are effective, next steps would include deter-
mining whether these implementation strategies can be
adapted to other settings and expanded to other co-
morbid conditions among PWID.
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